Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.57
+2.30 (1.10%)
AAPL  255.63
+1.84 (0.73%)
AMD  210.21
+6.78 (3.33%)
BAC  49.27
+0.52 (1.07%)
GOOG  294.90
+8.04 (2.80%)
META  579.23
+7.10 (1.24%)
MSFT  369.37
-0.80 (-0.22%)
NVDA  175.75
+1.35 (0.77%)
ORCL  145.23
-1.88 (-1.28%)
TSLA  381.26
+9.51 (2.56%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.